BRISTOL-MYERS SQUIBB COMPANY (BMY) FY2024 YTD Q3 Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2024-01-01 to 2024-09-30

Swipe to see the full flow
BRISTOL-MYERS SQUIBB COMPANY cash flow reconciliation, Jan 1, 2024 through Sep 30, 2024One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Acquired IPRD → operating reconciliation: $13,343,000,000.00Depreciation and amortization, net → operating reconciliation: $7,720,000,000.00Rebates and discounts → operating reconciliation: $1,889,000,000.00Impairment charges → operating reconciliation: $1,010,000,000.00Stock-based compensation → operating reconciliation: $387,000,000.00Other adjustments → operating reconciliation: $123,000,000.00Receivables → operating reconciliation: $121,000,000.00operating reconciliation → Net cash from operating activities: $10,751,000,000.00operating reconciliation → Net (loss)/earnings: $9,009,000,000.00operating reconciliation → Income taxes payable: $1,381,000,000.00operating reconciliation → Deferred income taxes: $1,298,000,000.00operating reconciliation → Divestiture gains and royalties: $838,000,000.00operating reconciliation → Inventories: $661,000,000.00operating reconciliation → Accounts payable: $333,000,000.00operating reconciliation → Equity investment (gains)/losses: $221,000,000.00operating reconciliation → Other: $101,000,000.00Proceeds from issuance of long-term debt → financing reconciliation: $12,883,000,000.00Proceeds from issuance of short-term debt obligations → financing reconciliation: $2,987,000,000.00Other short-term financing obligations, net → financing reconciliation: $504,000,000.00financing reconciliation → Net cash from financing activities: $6,769,000,000.00financing reconciliation → Dividends: $3,645,000,000.00financing reconciliation → Repayments of short-term debt obligations: $3,000,000,000.00financing reconciliation → Repayments of long-term debt: $2,873,000,000.00financing reconciliation → Stock option proceeds and other, net: $87,000,000.00Net cash used in investing activities → investing reconciliation: $21,156,000,000.00Sale and maturities of marketable debt securities → investing reconciliation: $1,060,000,000.00Divestiture and other proceeds → investing reconciliation: $766,000,000.00Proceeds from sales of equity investments → investing reconciliation: $60,000,000.00investing reconciliation → Acquisition and other payments, net of cash acquired: $21,774,000,000.00investing reconciliation → Capital expenditures: $870,000,000.00investing reconciliation → Purchase of marketable debt securities: $398,000,000.00Exchange-rate effect → Cash sources and uses: $10,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $11,519,000,000.00Net cash from operating activities → Cash sources and uses: $10,751,000,000.00Net cash from financing activities → Cash sources and uses: $6,769,000,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $7,893,000,000.00Cash sources and uses → Net cash used in investing activities: $21,156,000,000.00Net (loss)/earnings: -$9,009,000,000.00Net (loss)/earnings−$9.01 BDepreciation and amortization, net: $7,720,000,000.00Depreciation & amortization+$7.72 BDeferred income taxes: -$1,298,000,000.00Deferred income taxes−$1.30 BStock-based compensation: $387,000,000.00Stock-based compensation+$387.00 MImpairment charges: $1,010,000,000.00Held-for-sale asset impairment+$1.01 BDivestiture gains and royalties: -$838,000,000.00Divestiture gains and royalties−$838.00 MEquity investment (gains)/losses: -$221,000,000.00Investment gain & loss−$221.00 MOther adjustments: $123,000,000.00Other non-cash items+$123.00 MReceivables: $121,000,000.00Receivables, net+$121.00 MInventories: -$661,000,000.00Inventories−$661.00 MAccounts payable: -$333,000,000.00Accounts payable−$333.00 MIncome taxes payable: -$1,381,000,000.00Income taxes payable−$1.38 BOther: -$101,000,000.00Other working capital, net−$101.00 MAcquired IPRD: $13,343,000,000.00Acquired IPRD+$13.34 BRebates and discounts: $1,889,000,000.00Other accrued liabilities+$1.89 BNet cash from operating activities: $10,751,000,000.00Operating cash+$10.75 Boperating reconciliation: $24,593,000,000.00Proceeds from issuance of short-term debt obligations: $2,987,000,000.00Commercial paper issued+$2.99 BStock option proceeds and other, net: -$87,000,000.00Stock option proceeds and other, net−$87.00 MProceeds from issuance of long-term debt: $12,883,000,000.00Debt issued+$12.88 BDividends: -$3,645,000,000.00Dividends paid−$3.65 BOther short-term financing obligations, net: $504,000,000.00Other short-term debt issued+$504.00 MRepayments of short-term debt obligations: -$3,000,000,000.00Commercial paper repaid−$3.00 BRepurchase of common stock: $0.00Repayments of long-term debt: -$2,873,000,000.00Long-term debt repaid−$2.87 BNet cash from financing activities: $6,769,000,000.00Financing cash+$6.77 Bfinancing reconciliation: $16,374,000,000.00Sale and maturities of marketable debt securities: $1,060,000,000.00AFS securities proceeds+$1.06 BPurchase of marketable debt securities: -$398,000,000.00Marketable securities purchases−$398.00 MCapital expenditures: -$870,000,000.00PP&E purchases−$870.00 MDivestiture and other proceeds: $766,000,000.00Divestiture and other proceeds+$766.00 MAcquisition and other payments, net of cash acquired: -$21,774,000,000.00Acquisitions, net of cash−$21.77 BProceeds from sales of equity investments: $60,000,000.00Equity securities sales+$60.00 MNet cash used in investing activities: -$21,156,000,000.00. Cash required to fund net payments.Investing cash−$21.16 Binvesting reconciliation: $23,042,000,000.00Cash sources and uses: $29,049,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $11,519,000,000.00Beginning cash$11.52 BEnding cash: Cash, cash equivalents, and restricted cash: $7,893,000,000.00Ending cash$7.89 BExchange-rate effect: $10,000,000.00FX effect+$10.00 MCASH RECONCILIATIONOperatingflowsFinancingflowsInvestingflowsNet loss −$9.01B + net operating adjustments $19.76B = operating cash +$10.75BFree cash flow$9.88 BOperating cash − cash spent on PP&ECash flow / Net incomeNot meaningfulOperating cash flow ÷ net incomeNet cash change−$3.63 BEnding cash − beginning cash
Chart details

BRISTOL-MYERS SQUIBB COMPANY cash flow reconciliation, Jan 1, 2024 through Sep 30, 2024

Cash flows for Jan 1, 2024 through Sep 30, 2024. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2023. Ending cash: Sep 30, 2024. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2023
11,519,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
10,751,000,000 US dollars. Net cash provided.
Net (loss)/earnings
negative 9,009,000,000 US dollars
Depreciation and amortization, net
7,720,000,000 US dollars
Deferred income taxes
negative 1,298,000,000 US dollars
Stock-based compensation
387,000,000 US dollars
Impairment charges
1,010,000,000 US dollars
Divestiture gains and royalties
negative 838,000,000 US dollars
Equity investment (gains)/losses
negative 221,000,000 US dollars
Other adjustments
123,000,000 US dollars
Receivables
121,000,000 US dollars
Inventories
negative 661,000,000 US dollars
Accounts payable
negative 333,000,000 US dollars
Income taxes payable
negative 1,381,000,000 US dollars
Other
negative 101,000,000 US dollars
Acquired IPRD
13,343,000,000 US dollars
Rebates and discounts
1,889,000,000 US dollars
Investing activities
negative 21,156,000,000 US dollars. Net cash used.
Sale and maturities of marketable debt securities
1,060,000,000 US dollars
Purchase of marketable debt securities
negative 398,000,000 US dollars
Capital expenditures
negative 870,000,000 US dollars
Divestiture and other proceeds
766,000,000 US dollars
Acquisition and other payments, net of cash acquired
negative 21,774,000,000 US dollars
Proceeds from sales of equity investments
60,000,000 US dollars
Financing activities
6,769,000,000 US dollars. Net cash provided.
Proceeds from issuance of short-term debt obligations
2,987,000,000 US dollars
Stock option proceeds and other, net
negative 87,000,000 US dollars
Proceeds from issuance of long-term debt
12,883,000,000 US dollars
Dividends
negative 3,645,000,000 US dollars
Other short-term financing obligations, net
504,000,000 US dollars
Repayments of short-term debt obligations
negative 3,000,000,000 US dollars
Repurchase of common stock
0 US dollars
Repayments of long-term debt
negative 2,873,000,000 US dollars
Operating adjustment reconciliation
24,593,000,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
16,374,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
23,042,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
10,000,000 US dollars
Ending cash on Sep 30, 2024
7,893,000,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
29,049,000,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
negative 3,626,000,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
Not meaningful. Operating cash flow divided by reconciliation net income for the same period. The ratio is not meaningful when net income is zero or negative.
Operating cash flow
10,751,000,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
870,000,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
9,881,000,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net loss −$9.01B + net operating adjustments $19.76B = operating cash +$10.75B. The loss reduces the earnings basis of the reconciliation; it is not a cash payment. The signed loss remains a deduction at the operating reconciliation junction.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 10,751,000,000 US dollars minus 870,000,000 US dollars equals 9,881,000,000 US dollars.
BRISTOL-MYERS SQUIBB COMPANY (BMY) FY2024 YTD Q3 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!